HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Michele Maio Selected Research

Histocompatibility Antigens Class I

3/2013Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide.
6/2007Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
4/2006Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications.
9/2003Epigenetic targets for immune intervention in human malignancies.
6/2003Methylation-regulated expression of HLA class I antigens in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Michele Maio Research Topics

Disease

67Melanoma (Melanoma, Malignant)
08/2015 - 01/2002
55Neoplasms (Cancer)
09/2015 - 01/2002
14Testicular Neoplasms (Testicular Cancer)
05/2014 - 01/2002
11Neoplasm Metastasis (Metastasis)
08/2015 - 01/2002
8Disease Progression
08/2015 - 02/2003
4Hematologic Neoplasms (Hematological Malignancy)
10/2005 - 02/2003
3Thrombocytopenia (Thrombopenia)
04/2015 - 01/2012
3Mesothelioma
04/2015 - 10/2013
3Neutropenia
04/2015 - 03/2014
2Colitis
05/2015 - 06/2014
2Fatigue
04/2015 - 06/2014
2Body Weight (Weight, Body)
01/2015 - 06/2011
2Exanthema (Rash)
03/2014 - 02/2013
2Diarrhea
02/2013 - 01/2012
1Myocarditis (Carditis)
05/2015
1Leukopenia
07/2014
1Prostatic Neoplasms (Prostate Cancer)
06/2014
1Keratoacanthoma
03/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2014
1Pruritus (Itching)
02/2013
1Neoplastic Cell Transformation
08/2007
1Primary Effusion Lymphoma
02/2005

Drug/Important Bio-Agent (IBA)

29AntigensIBA
01/2015 - 01/2002
28ipilimumabIBA
07/2015 - 08/2009
13AntibodiesIBA
01/2015 - 03/2002
11DNA (Deoxyribonucleic Acid)IBA
06/2014 - 01/2002
8Dacarbazine (DIC)FDA LinkGeneric
04/2015 - 04/2010
7decitabine (5-aza-2'-deoxycytidine)FDA Link
06/2007 - 01/2002
5CP-675,206IBA
04/2015 - 10/2010
5Messenger RNA (mRNA)IBA
10/2013 - 02/2002
5Histocompatibility Antigens Class IIBA
03/2013 - 06/2003
4Interleukin-2 (IL2)IBA
08/2015 - 03/2002
4VaccinesIBA
01/2015 - 03/2002
4Histones (Histone)IBA
10/2013 - 09/2003
3Monoclonal AntibodiesIBA
06/2015 - 02/2002
3MART-1 AntigenIBA
08/2014 - 05/2012
3HLA Antigens (Human Leukocyte Antigens)IBA
06/2014 - 09/2003
3HLA-DR Antigens (HLA-DR)IBA
03/2014 - 09/2003
3PeptidesIBA
05/2013 - 05/2012
3Interferon-alpha (Interferon Alfa)FDA Link
10/2012 - 08/2006
3Glycoproteins (Glycoprotein)IBA
06/2011 - 02/2002
3Biological Markers (Surrogate Marker)IBA
01/2011 - 01/2008
3Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2006 - 10/2002
2Immunoglobulin G (IgG)IBA
04/2015 - 03/2002
2PlatinumIBA
04/2015 - 10/2013
2Interleukin-4 (Interleukin 4)IBA
08/2014 - 03/2002
2MicroRNAs (MicroRNA)IBA
10/2013 - 01/2010
2HLA-A*0201 antigenIBA
05/2013 - 01/2010
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2013 - 06/2007
2temozolomide (Temodar)FDA LinkGeneric
02/2013 - 10/2010
2Cancer VaccinesIBA
12/2012 - 03/2008
2fotemustine (Muphoran)IBA
09/2012 - 10/2010
2CytotoxinsIBA
10/2010 - 12/2009
2InterferonsIBA
10/2010 - 01/2009
2Proteins (Proteins, Gene)IBA
01/2009 - 03/2004
2vitespinIBA
08/2006 - 10/2002
2Histocompatibility Antigens Class IIIBA
08/2004 - 09/2003
2Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
09/2003 - 02/2003
2Complement System Proteins (Complement)IBA
03/2002 - 02/2002
1CytokinesIBA
08/2015
1cytotoxic T-lymphocyte antigen 4IBA
07/2015
1Lipase (Acid Lipase)FDA Link
04/2015
1Alanine Transaminase (SGPT)IBA
04/2015
1Interleukin-10 (Interleukin 10)IBA
02/2015
1SodiumIBA
07/2014
1Paclitaxel (Taxol)FDA LinkGeneric
07/2014
1Immunologic Factors (Immunomodulators)IBA
06/2014
1Carbon MonoxideIBA
06/2014
1Histone Deacetylases (Histone Deacetylase)IBA
06/2014
1MethyltransferasesIBA
06/2014
1Dihydrotachysterol (AT 10)IBA
06/2014
1docetaxel (Taxotere)FDA Link
06/2014
1Nucleosomes (Nucleosome)IBA
10/2013
1Thymidine KinaseIBA
06/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2013
1Cytidine DeaminaseIBA
03/2013
1antineoplaston A10 (A 10)IBA
03/2013
1EAP protocolIBA
01/2013
1ThymosinIBA
10/2012
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2012
1Alanine (L-Alanine)FDA Link
01/2012
1Phosphotransferases (Kinase)IBA
06/2011
1PLX4032IBA
06/2011
1CP-870,893IBA
10/2010
1LigandsIBA
10/2010
1thymalfasinIBA
04/2010
1Caveolin 1IBA
01/2009
1HLA-A2 Antigen (HLA A2 Antigen)IBA
06/2007
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2006
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2003

Therapy/Procedure

24Immunotherapy
09/2015 - 01/2002
7Drug Therapy (Chemotherapy)
04/2015 - 08/2009
3Biological Therapy
05/2011 - 01/2008
2Retreatment
01/2014 - 01/2014
1Intralesional Injections
08/2015
1Radiotherapy
06/2014
1Castration
06/2014
1Lasers (Laser)
01/2014
1Heterologous Transplantation (Xenotransplantation)
04/2006
1Immunomodulation
10/2005